1. Home
  2. KLTR vs DBVT Comparison

KLTR vs DBVT Comparison

Compare KLTR & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTR
  • DBVT
  • Stock Information
  • Founded
  • KLTR 2006
  • DBVT 2002
  • Country
  • KLTR United States
  • DBVT France
  • Employees
  • KLTR N/A
  • DBVT N/A
  • Industry
  • KLTR EDP Services
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KLTR Technology
  • DBVT Health Care
  • Exchange
  • KLTR Nasdaq
  • DBVT Nasdaq
  • Market Cap
  • KLTR 302.6M
  • DBVT 260.5M
  • IPO Year
  • KLTR 2021
  • DBVT N/A
  • Fundamental
  • Price
  • KLTR $1.68
  • DBVT $9.91
  • Analyst Decision
  • KLTR Buy
  • DBVT Buy
  • Analyst Count
  • KLTR 3
  • DBVT 4
  • Target Price
  • KLTR $2.83
  • DBVT $14.81
  • AVG Volume (30 Days)
  • KLTR 264.1K
  • DBVT 33.0K
  • Earning Date
  • KLTR 11-05-2025
  • DBVT 11-05-2025
  • Dividend Yield
  • KLTR N/A
  • DBVT N/A
  • EPS Growth
  • KLTR N/A
  • DBVT N/A
  • EPS
  • KLTR N/A
  • DBVT N/A
  • Revenue
  • KLTR $181,350,000.00
  • DBVT $3,800,000.00
  • Revenue This Year
  • KLTR $3.43
  • DBVT $1,743.46
  • Revenue Next Year
  • KLTR $2.96
  • DBVT $1,045.66
  • P/E Ratio
  • KLTR N/A
  • DBVT N/A
  • Revenue Growth
  • KLTR 2.56
  • DBVT N/A
  • 52 Week Low
  • KLTR $1.23
  • DBVT $2.21
  • 52 Week High
  • KLTR $2.82
  • DBVT $12.78
  • Technical
  • Relative Strength Index (RSI)
  • KLTR 55.44
  • DBVT 55.75
  • Support Level
  • KLTR $1.67
  • DBVT $9.58
  • Resistance Level
  • KLTR $1.74
  • DBVT $10.50
  • Average True Range (ATR)
  • KLTR 0.09
  • DBVT 0.49
  • MACD
  • KLTR 0.03
  • DBVT 0.08
  • Stochastic Oscillator
  • KLTR 75.61
  • DBVT 67.22

About KLTR Kaltura Inc.

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: